Pharmaceutical Research and Manufacturers of America
Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 29 Jan 2025 | Chiara Galiffa Cabinet member | EU-US trade | — |
| 29 Jan 2025 | Sabine Weyand Director-General | Transatlantic trade relations in the second Trump administration. | — |
| 29 Jan 2025 | Chiara Galiffa Cabinet member | EU-US trade | SRC |
| 29 Jan 2025 | Matthias Jorgensen Head of Unit | Transatlantic trade relations in the second Trump administration. | SRC |
| 29 Jan 2025 | Sabine Weyand Director-General | Transatlantic trade relations in the second Trump administration. | SRC |
| 29 Jan 2025 | Matthias Jorgensen Head of Unit | Transatlantic trade relations in the second Trump administration. | — |
| 27 Jan 2025 | Ioan-Dragos Tudorache Cabinet member | Policies to improve EU’s business environment and competitiveness, business concerns related to regulatory burdens, and key sectoral challenges. | — |
| 27 Jan 2025 | Ioan-Dragos Tudorache Cabinet member | Policies to improve EU’s business environment and competitiveness, business concerns related to regulatory burdens, and key sectoral challenges. | SRC |
| 05 Jun 2023 | Zaneta Vegnere Cabinet member | Trade & Technology Council, Global Steel and Aluminum Arrangement, Critical Minerals Agreement | SRC |
| 05 Jun 2023 | Zaneta Vegnere Cabinet member | Trade & Technology Council, Global Steel and Aluminum Arrangement, Critical Minerals Agreement | — |
Mission & Goals
Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA's mission is to conduct effective advocacy for public policies that encourage discovery of important new medicines for patients by pharmaceutical and biotechnology research companies.
EU Legislative Interests
European Commission health and pharmaceutical policies, including intellectual property and trade policy. EU Pharmaceutical Legislation, Patent Package and related issues. TRIPS waiver advocacy. Engagement concerning U.S.-EU Trade and Technology Council.
Interests Represented
Promotes their own interests or the collective interests of their members
Organisation Members
http://www.phrma.org/about/members